What is the management of ventricular (V) tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Ventricular Tachycardia

Direct current cardioversion is recommended as first-line treatment for patients presenting with sustained ventricular tachycardia (VT) and hemodynamic instability. 1

Initial Assessment and Classification

The management of VT depends primarily on two key factors:

  1. Hemodynamic stability - Is the patient stable or unstable?
  2. VT morphology - Is the VT monomorphic or polymorphic?

Hemodynamically Unstable VT

For patients with hemodynamic instability (hypotension, altered mental status, signs of shock, or severe heart failure):

  • Immediate synchronized cardioversion at maximum output 1
  • Sedate patient first if conscious but unstable 1
  • Place defibrillator patches at least 8cm from ICD generator if present 1

Hemodynamically Stable VT

Monomorphic VT:

  1. First-line pharmacological treatment:

    • IV procainamide: 10 mg/kg at 50-100 mg/min over 10-20 minutes 1, 2
    • Monitor blood pressure and ECG during administration
  2. Alternative medications:

    • IV amiodarone: 150 mg over 10 minutes (for patients with heart failure or suspected ischemia) 1, 3
    • Can repeat as needed to maximum dose of 2.2g/24 hours 1
    • IV sotalol: 1.5 mg/kg over 5 minutes (avoid in patients with prolonged QT) 1
    • IV lidocaine: 1-1.5 mg/kg IV bolus, followed by maintenance infusion 1-4 mg/min (only for VT associated with acute myocardial ischemia) 1
  3. If medications fail:

    • Synchronized cardioversion (after appropriate sedation) 1
    • Transvenous catheter pace termination for refractory or recurrent VT 1

Polymorphic VT:

  1. First-line treatment:

    • Direct current cardioversion with appropriate sedation 1
  2. Pharmacological management:

    • IV beta blockers: First choice, especially if ischemia is suspected 1
    • IV amiodarone: 150 mg over 10 minutes (in absence of long QT syndrome) 1
    • IV lidocaine: May be considered if associated with acute myocardial ischemia 1
  3. Additional measures:

    • Urgent angiography with view to revascularization if myocardial ischemia cannot be excluded 1

Special Considerations

Incessant VT or Electrical Storm

  • Urgent catheter ablation is recommended for patients with scar-related heart disease presenting with incessant VT or electrical storm 1

Recurrent ICD Shocks

  • Catheter ablation is recommended for patients with ischemic heart disease and recurrent ICD shocks due to sustained VT 1

LV Fascicular VT

  • IV verapamil or beta-blockers for patients presenting with LV fascicular VT (RBBB morphology and left axis deviation) 1

Common Pitfalls

  1. Misdiagnosis of wide-complex tachycardia: Always presume wide-QRS tachycardia to be VT if diagnosis is unclear 1

  2. Inappropriate medication use: Calcium channel blockers such as verapamil and diltiazem should not be used to terminate wide-QRS-complex tachycardia of unknown origin, especially in patients with myocardial dysfunction 1

  3. Delayed cardioversion: Do not delay cardioversion in unstable patients while attempting medical therapy

  4. Inadequate monitoring: Close monitoring of blood pressure and cardiovascular status is essential during administration of antiarrhythmic medications, particularly in patients with heart failure 1

  5. Improper amiodarone administration: Infusing amiodarone too rapidly or at concentrations >3 mg/mL can cause serious adverse effects including hepatocellular necrosis and acute renal failure 3

Long-term Management

After acute stabilization:

  • Consider catheter ablation after first episode of sustained VT in patients with ischemic heart disease and an ICD 1
  • Evaluate for underlying structural heart disease with imaging (preferably cardiac MRI) 1
  • Consider ICD implantation for prevention of sudden cardiac death in appropriate patients

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.